Open AccessFollicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles
Author(s) -
Bindu N Mehta,
M. Chimote,
Nishad Chimote,
N. Nath,
Natachandra Chimote
Publication year - 2013
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.117168
Subject(s) - oocyte , anti müllerian hormone , in vitro fertilisation , andrology , embryo quality , human fertilization , embryo transfer , follicular phase , antral follicle , follicular fluid , ovarian reserve , pregnancy rate , pregnancy , embryo , biology , gynecology , hormone , medicine , endocrinology , infertility , anatomy , genetics , microbiology and biotechnology
Oocyte quality may be a governing factor in influencing in vitro fertilization (IVF) outcomes. However, morphological evaluation of oocyte quality is difficult in conventional IVF cycles. Follicular-fluid (FF), the site for oocyte growth and development, has not yet been sufficiently explored to obtain a marker indicative of oocyte quality. Anti-Mullerian hormone (AMH) is produced by granulosa cells of preantral and early-antral follicles and is released in FF.